{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:08:02Z","timestamp":1791198482404,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.vaccine.2005.04.025","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T01:27:36Z","timestamp":1116120456000},"page":"4489-4499","source":"Crossref","is-referenced-by-count":95,"title":["Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice"],"prefix":"10.1016","volume":"23","author":[{"given":"Marie-No\u00eblle","family":"M\u00e9v\u00e9lec","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Desolme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Bruneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Buzoni-Gatel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2005.04.025_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/vr.129.5.89","article-title":"Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant","volume":"129","author":"Buxton","year":"1991","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2005.04.025_bib2","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.4049\/jimmunol.147.10.3501","article-title":"A purified parasite antigen (P30) mediates CD8+ Tcells immunity against fatal Toxoplasma gondii infection in mice","volume":"147","author":"Khan","year":"1991","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2005.04.025_bib3","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/IAI.64.6.2158-2166.1996","article-title":"Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection","volume":"64","author":"Debard","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.025_bib4","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.4049\/jimmunol.149.11.3636","article-title":"Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen","volume":"14","author":"Darcy","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.04.025_bib5","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1128\/IAI.66.9.4503-4506.1998","article-title":"Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukine-12 against toxoplasmosis in mice","volume":"66","author":"Letscher-Bru","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.025_bib6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0264-410X(98)00039-5","article-title":"Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii","volume":"16","author":"Petersen","year":"1998","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2005.04.025_bib7","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/IAI.71.11.6615-6619.2003","article-title":"Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB\/c mice but not in CBA\/J mice","volume":"71","author":"Letscher-Bru","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.025_bib8","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1128\/JVI.70.9.6119-6125.1996","article-title":"Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery","volume":"70","author":"Pertmer","year":"1996","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2005.04.025_bib9","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1128\/IAI.67.12.6358-6363.1999","article-title":"Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene","volume":"67","author":"Nielsen","year":"1999","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2005.04.025_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/315186","article-title":"Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents","volume":"181","author":"Angus","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.04.025_bib11","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/S0264-410X(03)00163-4","article-title":"DNA vaccination with the immunodominant tachyzo\u00efte surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission","volume":"21","author":"Couper","year":"2003","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2005.04.025_bib12","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/S0264-410X(00)00035-9","article-title":"Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene","volume":"18","author":"Desolme","year":"2000","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2005.04.025_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-0556-2-17","article-title":"DNA vaccines: designing strategies against parasitic infections","volume":"2","author":"Ivory","year":"2004","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.vaccine.2005.04.025_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1051\/parasite\/1970454389","article-title":"Int\u00e9r\u00eat exp\u00e9rimental d\u2019une souche de toxoplasme peu pathogene pour la souris","volume":"45","author":"Laugier","year":"1970","journal-title":"Ann Parasitol Hum Comp"},{"issue":"1","key":"10.1016\/j.vaccine.2005.04.025_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0020-7519(01)00301-0","article-title":"Microsatellite analysis of Toxoplasma gondii shows considerable polymorphism srtuctured into two main groups","volume":"32","author":"Ajzenberg","year":"2002","journal-title":"Int J Parasitol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.04.025_bib16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1086\/342663","article-title":"Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings","volume":"186","author":"Ajzenberg","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2005.04.025_bib17","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.4049\/jimmunol.141.10.3584","article-title":"Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii","volume":"141","author":"Burg","year":"1988","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2005.04.025_bib18","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1128\/IAI.58.5.1240-1246.1990","article-title":"Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens","volume":"58","author":"Chard\u00e8s","year":"1990","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.025_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182000066695","article-title":"Surface antigens of Toxoplasma gondii","volume":"97","author":"Couvreur","year":"1988","journal-title":"Parasitol"},{"key":"10.1016\/j.vaccine.2005.04.025_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/hum.1993.4.2-151","article-title":"Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression","volume":"4","author":"Davis","year":"1993","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2005.04.025_bib21","first-page":"183","article-title":"Mapping of B epitopes in GRA4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by oral route","volume":"20","author":"M\u00e9v\u00e9lec","year":"1998","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2005.04.025_bib22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.131.2.977","article-title":"Western blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies","volume":"131","author":"Sharma","year":"1983","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.04.025_bib23","first-page":"175","article-title":"Transmission of toxoplasmosis via milk from lactating mice","volume":"92","author":"Pettersen","year":"1984","journal-title":"Acta Pathol Microbiol Immunol Scand"},{"key":"10.1016\/j.vaccine.2005.04.025_bib24","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2005.04.025_bib25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0264-410X(02)00692-8","article-title":"Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice","volume":"21","author":"Fachado","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.04.025_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00062752-200005000-00007","article-title":"Uses of granulocyte-macrophage colony-stimulating factor in vaccine development","volume":"7","author":"Warren","year":"2000","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.vaccine.2005.04.025_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/10430340050016049","article-title":"Macrophage colony-stimulating factor can modulate immune responses and attract dendritic cells in vivo","volume":"11","author":"Kim","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2005.04.025_bib28","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","article-title":"Decreased resistance of B cell deficient mice to infection with T. gondii despite unimpaired expression of IFN-gamma, TNF-alfa and inducible nitric oxide synthasem","volume":"164","author":"Kang","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.04.025_bib29","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","article-title":"Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine","volume":"146","author":"Gazzinelli","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.04.025_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-\u03b3: the major mediator of resistance against Toxoplasma gondii","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.vaccine.2005.04.025_bib31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/0264-410X(94)90147-3","article-title":"Congenital toxoplasmosis in the Balb\/c mouse: prevention of vertical disease transmission and fetal death by vaccination","volume":"12","author":"Roberts","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2005.04.025_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1590\/S0074-02762001000100011","article-title":"Vertical toxoplasmosis in a murine model. Protection after immunization with antigens of Toxoplasma gondii incorporated into liposomes","volume":"96","author":"Elsaid","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9","key":"10.1016\/j.vaccine.2005.04.025_bib33","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1128\/IAI.68.9.4948-4953.2000","article-title":"Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model","volume":"68","author":"Haumont","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.025_bib34","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1128\/IAI.38.3.1164-1171.1982","article-title":"Effect of pregnancy on resistance to Listeria monocytogenes and Toxoplasma gondii infections in mice","volume":"38","author":"Luft","year":"1982","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2005.04.025_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1348-0421.1992.tb01644.x","article-title":"Correlation between increased susceptibility to primary Toxoplasma gondii infection and depressed production of gamma interferon in pregant mice","volume":"36","author":"Shirahata","year":"1992","journal-title":"Microbiol Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2005.04.025_bib36","first-page":"279","article-title":"Immune response in a murine model of congenital toxoplasmosis: increased susceptibility of pregnant mice and transplacental passage of Toxoplasma gondii are type 2-dependant","volume":"39","author":"Thouvenin","year":"1997","journal-title":"Parasitologia"},{"key":"10.1016\/j.vaccine.2005.04.025_bib37","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.4049\/jimmunol.151.9.4562","article-title":"Synthesis of T helper 2-type cytokines at the maternal-fetal interface","volume":"151","author":"Lin","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2005.04.025_bib38","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.4049\/jimmunol.152.5.2411","article-title":"Differential cytokine expression in maternal blood and placenta during murine gestation","volume":"152","author":"Delassus","year":"1994","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2005.04.025_bib39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1348-0421.1993.tb01680.x","article-title":"Enhancement by recombinant human interleukin 2 of host resistance to Toxoplasma gondii infection in pregnant mice","volume":"37","author":"Shirahata","year":"1993","journal-title":"Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.04.025_bib40","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1128\/IAI.72.3.1397-1401.2004","article-title":"Role of NK cells and gamma interferon in transplacental passage of Toxoplasma gondii in a mouse model of primary infection","volume":"72","author":"Abou-Bacar","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2005.04.025_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0020-7519(97)00168-9","article-title":"The role of IL-4 in adult acquired and congenital toxoplasmosis","volume":"28","author":"Alexander","year":"1998","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2005.04.025_bib42","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.4049\/jimmunol.164.9.4768","article-title":"Neutralization of maternal IL-4 modulates congenital protozoal transmission: comparison of innate versus acquired immune responses","volume":"164","author":"Long","year":"2000","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05004664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X05004664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T02:51:46Z","timestamp":1683082306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X05004664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":42,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0264410X05004664"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.04.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}